{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:11:35Z","timestamp":1771470695901,"version":"3.50.1"},"update-to":[{"DOI":"10.1016\/j.lfs.2024.122669","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000}}],"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003008","name":"Ministry of Higher Education, Egypt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.lfs.2024.122669","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T02:36:46Z","timestamp":1714099006000},"page":"122669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["WITHDRAWN: Assessment of the therapeutic potential of a novel phosphoramidate acyclic nucleoside on induced hepatocellular carcinoma in rat model"],"prefix":"10.1016","author":[{"given":"Youssef A.","family":"Said","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif F.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam I.","family":"Halim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Abd","family":"El-Moneim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122669_bb0005","doi-asserted-by":"crossref","unstructured":"G. Wang, Q. Wang, N. Liang, H. Xue, T. Yang, X. Chen, Z. Qiu, C. Zeng, T. Sun, W. Yuan, C. Liu, Z. Chen, X. He, Oncogenic driver genes and tumor microenvironment determine the type of liver cancer, Cell Death Dis. 2020 115 11 (2020) 1\u201313. doi:https:\/\/doi.org\/10.1038\/s41419-020-2509-x.","DOI":"10.1038\/s41419-020-2509-x"},{"key":"10.1016\/j.lfs.2024.122669_bb0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41575-018-0033-6","article-title":"Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research","volume":"15","author":"Brown","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2024.122669_bb0015","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.lfs.2024.122669_bb0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/JHC.S285726","article-title":"Elucidating the molecular basis of Sorafenib resistance in HCC: current findings and future directions","volume":"8","author":"Fornari","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.lfs.2024.122669_bb0025","doi-asserted-by":"crossref","unstructured":"T.-P. JEE, Hepatocellular Carcinoma [Internet], (2019). doi:10.15586\/HEPATOCELLULARCARCINOMA.2019.","DOI":"10.15586\/hepatocellularcarcinoma.2019"},{"key":"10.1016\/j.lfs.2024.122669_bb0030","first-page":"25","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial, lancet","volume":"10","author":"Cheng","year":"2009","journal-title":"Oncol"},{"key":"10.1016\/j.lfs.2024.122669_bb0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2024.122669_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003495-200969020-00006","article-title":"Sorafenib: a review of its use in advanced hepatocellular carcinoma","volume":"69","author":"Keating","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2024.122669_bb0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3858\/emm.2011.43.5.033","article-title":"Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma","volume":"43","author":"Jang","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2024.122669_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.991052","article-title":"Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: mechanistic insights","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122669_bb0055","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1021\/acs.chemrev.6b00209","article-title":"Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs","volume":"116","author":"Shelton","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.lfs.2024.122669_bb0060","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2024.122669_bb0065","doi-asserted-by":"crossref","first-page":"24662","DOI":"10.1021\/acsami.0c08534","article-title":"Oxygen self-sufficient Core-Shell metal-organic framework-based smart Nanoplatform for enhanced synergistic chemotherapy and photodynamic therapy","volume":"12","author":"Ren","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.lfs.2024.122669_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17425247.2020.1713087","article-title":"Permeation enhancers in transdermal drug delivery: benefits and limitations","volume":"17","author":"Kov\u00e1\u010dik","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.lfs.2024.122669_bb0075","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1016\/j.bmc.2012.05.055","article-title":"Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents","volume":"20","author":"Tang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2024.122669_bb0080","series-title":"Phosphoramidates and Phosphonamidates (ProTides) with Antiviral Activity","author":"Slusarczyk","year":"2018"},{"key":"10.1016\/j.lfs.2024.122669_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3851\/IMP2012","article-title":"Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy","volume":"22","author":"Pertusati","year":"2012","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.lfs.2024.122669_bb0090","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/cmdc.200900289","article-title":"Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells","volume":"4","author":"Mehellou","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.lfs.2024.122669_bb0095","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1021\/jm200815w","article-title":"Phosphoramidate ProTides of the anticancer agent FUDR successfully deliver the preformed bioactive monophosphate in cells and confer advantage over the parent nucleoside","volume":"54","author":"McGuigan","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2024.122669_bb0100","doi-asserted-by":"crossref","unstructured":"H.A. Khatab, S.F. Hammad, E.M. El-Fakharany, A.I. Hashem, E.A.E. El-Helw, Synthesis and cytotoxicity evaluation of novel 1,8-acridinedione derivatives bearing phthalimide moiety as potential antitumor agents, Sci. Reports 2023 131 13 (2023) 1\u201321. doi:https:\/\/doi.org\/10.1038\/s41598-023-41970-0.","DOI":"10.1038\/s41598-023-41970-0"},{"key":"10.1016\/j.lfs.2024.122669_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.lfs.2024.122669_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103197","article-title":"Vernodalidimer L, a sesquiterpene lactone dimer from Vernonia extensa and anti-tumor effects of vernodalin, vernolepin, and vernolide on HepG2 liver cancer cells","volume":"92","author":"Thongnest","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.lfs.2024.122669_bb0115","doi-asserted-by":"crossref","unstructured":"O.A. Pe\u00f1a-Mor\u00e1n, M.L. Villarreal, L. \u00c1lvarez-Berber, A. Meneses-Acosta, V. Rodr\u00edguez-L\u00f3pez, Cytotoxicity, Post-treatment recovery, and selectivity analysis of naturally occurring Podophyllotoxins from Bursera fagaroides var. fagaroides on breast Cancer cell lines, Molecules 21 (2016). doi:https:\/\/doi.org\/10.3390\/MOLECULES21081013.","DOI":"10.3390\/molecules21081013"},{"key":"10.1016\/j.lfs.2024.122669_bb0120","doi-asserted-by":"crossref","unstructured":"E. Oghenesuvwe, E.E. Ilodigwe, E.O. Erhirhie, Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance Acute toxicity (LD 50 ) test, (2018). doi:https:\/\/doi.org\/10.2478\/intox-2018-0001.","DOI":"10.2478\/intox-2018-0001"},{"key":"10.1016\/j.lfs.2024.122669_bb0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.20538","article-title":"Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis","volume":"41","author":"Schiffer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2024.122669_bb0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in Oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2024.122669_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.lfs.2024.122669_bb0140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0002-9378(79)90708-7","article-title":"Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood","volume":"135","author":"Yoshioka","year":"1979","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.lfs.2024.122669_bb0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","article-title":"Oxidative damage to proteins: spectrophotometric method for carbonyl assay","volume":"233","author":"Reznick","year":"1994","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.lfs.2024.122669_bb0150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.lfs.2024.122669_bb0155","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1158\/1535-7163.MCT-16-0602-T","article-title":"Efficacy of AKT inhibitor ARQ 092 compared with sorafenib in a cirrhotic rat model with hepatocellular carcinoma","volume":"16","author":"Roth","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2024.122669_bb0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jss.2014.04.019","article-title":"Postoperative but not preoperative treatment with sorafenib inhibits liver regeneration in rats","volume":"191","author":"Andersen","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.lfs.2024.122669_bb0165","unstructured":"Sorafenib Tosylate SAFETY DATA Sheet, u. S. Pharmacop. (n.d.). www.usp.org (accessed November 7, 2023)."},{"key":"10.1016\/j.lfs.2024.122669_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2024.122669_bb0175","doi-asserted-by":"crossref","unstructured":"P. Varakumar, K. Rajagopal, B. Aparna, K. Raman, G. Byran, C.M. Gon\u00e7alves Lima, S. Rashid, M.H. Nafady, T. Bin Emran, S. Wybraniec, Acridine as an Anti-Tumour Agent: A Critical Review, Mol. 2023, Vol. 28, Page 193 28 (2022) 193. doi:https:\/\/doi.org\/10.3390\/MOLECULES28010193.","DOI":"10.3390\/molecules28010193"},{"key":"10.1016\/j.lfs.2024.122669_bb0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejphar.2008.11.044","article-title":"Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II","volume":"602","author":"Oppegard","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122669_bb0185","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cmdc.201600156","article-title":"The ProTides boom","author":"Mehellou","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.lfs.2024.122669_bb0190","article-title":"Amino acids in the development of prodrugs","volume":"23","author":"Vale","year":"2018","journal-title":"Mol. A J. Synth. Chem. Nat. Prod. Chem."},{"key":"10.1016\/j.lfs.2024.122669_bb0195","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1080\/14756366.2021.1953997","article-title":"Synthesis and anti-hepatocellular carcinoma activity of aminopyridinol-sorafenib hybrids","volume":"36","author":"Awasthi","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.lfs.2024.122669_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38264-w","article-title":"New proapoptotic chemotherapeutic agents based on the quinolone-3-carboxamide scaffold acting by VEGFR-2 inhibition","volume":"13","author":"El-Fakharany","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122669_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117048","article-title":"meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: synthesis, biological evaluation and molecular docking studies","volume":"74","author":"Limpachayaporn","year":"2022","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.lfs.2024.122669_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ph15050504","article-title":"The design and synthesis of a new series of 1,2,3-Triazole-cored structures tethering aryl urea and their highly selective cytotoxicity toward HepG2","volume":"15","author":"Oekchuae","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.lfs.2024.122669_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104831","article-title":"Synthesis of sorafenib analogues incorporating a 1,2,3-triazole ring and cytotoxicity towards hepatocellular carcinoma cell lines","volume":"112","author":"Palakhachane","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.lfs.2024.122669_bb0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/aps.2014.122","article-title":"Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1","volume":"36","author":"Wei","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2024.122669_bb0225","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/aps.2017.156","article-title":"Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling","volume":"39","author":"Zhang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2024.122669_bb0230","series-title":"Ameliorative Effects of Aspergillus Awamori against the Initiation of Hepatocarcinogenesis Induced by Diethylnitrosamine in a Rat Model: Regulation of Cyp19 and p53 Gene Expression, Antioxidants (Basel, Switzerland)","volume":"vol. 10","author":"Assar","year":"2021"},{"key":"10.1016\/j.lfs.2024.122669_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/toxics11020107","article-title":"Impending chemotherapeutic impact of Arthrospira platensis nanoparticles and\/or Sorafenib against hepatocellular carcinoma through modulation of antioxidant status, tumor marker genes, and anti-inflammatory signaling pathways","volume":"11","author":"Ghamry","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.lfs.2024.122669_bb0240","first-page":"475","article-title":"Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with Clofibrate or Diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility","volume":"76","author":"Greaves","year":"1986","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2024.122669_bb0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/B978-0-323-35775-3.00001-1","article-title":"Mechanisms and morphology of cellular injury, adaptation, and death","author":"Miller","year":"2017","journal-title":"Pathol. Basis Vet. Dis."},{"key":"10.1016\/j.lfs.2024.122669_bb0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10238-016-0416-3","article-title":"Sorafenib effect on liver neoplastic changes in rats: more than a kinase inhibitor","volume":"17","author":"El-Ashmawy","year":"2017","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122669_bb0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/cncr.10311","article-title":"Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples","volume":"96","author":"Siddiqui","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2024.122669_bb0260","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.31557\/APJCP.2019.20.8.2551","article-title":"The carcinogenic agent Diethylnitrosamine induces early oxidative stress, inflammation and proliferation in rat liver, stomach and Colon: protective effect of ginger extract","volume":"20","author":"Mansour","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.lfs.2024.122669_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.fct.2018.11.014","article-title":"Neferine suppresses diethylnitrosamine-induced lung carcinogenesis in Wistar rats","volume":"123","author":"Sivalingam","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2024.122669_bb0270","article-title":"Histopathology of hepatocellular carcinoma-when and what","volume":"8","author":"Gisder","year":"2022","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.lfs.2024.122669_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22062935","article-title":"Cyclin-dependent kinases (CDK) and their role in diseases development-review","volume":"22","author":"\u0141ukasik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122669_bb0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.29781","article-title":"Hepatocellular carcinoma\u2013related cyclin D1 is selectively regulated by autophagy degradation system","volume":"68","author":"Wu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2024.122669_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194981","article-title":"DEN-induced rat model reproduces key features of human hepatocellular carcinoma","volume":"13","author":"Kurma","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2024.122669_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0217009","article-title":"Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine\/phenobarbital-induced hepatocellular carcinoma in mice","volume":"14","author":"Gani","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2024.122669_bb0295","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317717259","article-title":"Evaluation of the antitumor activity of platinum nanoparticles in the treatment of hepatocellular carcinoma induced in rats","volume":"39","author":"Medhat","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2024.122669_bb0300","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12011-019-01941-x","article-title":"Biochemical, toxicological, and histopathological outcome in rat brain following treatment with NiO and NiO nanoparticles","volume":"196","author":"Marzban","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.lfs.2024.122669_bb0305","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s11695-007-9242-8","article-title":"Plasma protein carbonyl and thiol stress before and after laparoscopic gastric banding in morbidly obese patients","volume":"17","author":"Uzun","year":"2007","journal-title":"Obes. Surg."},{"key":"10.1016\/j.lfs.2024.122669_bb0310","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1039\/C6TX00416D","article-title":"Downregulation of catalase by CuO nanoparticles via hypermethylation of CpG island II on the catalase promoter","volume":"6","author":"Chibber","year":"2017","journal-title":"Toxicol. Res. (Camb)."},{"key":"10.1016\/j.lfs.2024.122669_bb0315","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00204-007-0278-2","article-title":"Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats","volume":"82","author":"Nishimura","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.lfs.2024.122669_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032539","article-title":"The role of alpha-fetoprotein (AFP) in contemporary oncology: the path from a diagnostic biomarker to an anticancer drug","volume":"24","author":"G\u0142owska-Ciemny","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122669_bb0325","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.7150\/jca.19181","article-title":"A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with hepatocellular carcinoma","volume":"8","author":"Wang","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.lfs.2024.122669_bb0330","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2796.2000.00705.x","article-title":"Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors","volume":"248","author":"Lechleitner","year":"2000","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.lfs.2024.122669_bb0335","article-title":"LINC01980 stimulates the progression of hepatocellular carcinoma via downregulating caspase 9","author":"Zang","year":"2020","journal-title":"J. B.U.ON."},{"key":"10.1016\/j.lfs.2024.122669_bb0340","doi-asserted-by":"crossref","unstructured":"X. Zhao, C. Tian, W.M. Puszyk, O.O. Ogunwobi, M. Cao, T. Wang, R. Cabrera, D.R. Nelson, C. Liu, OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma, Lab. Investig. 2012 931 93 (2012) 8\u201319. doi:https:\/\/doi.org\/10.1038\/labinvest.2012.144.","DOI":"10.1038\/labinvest.2012.144"},{"key":"10.1016\/j.lfs.2024.122669_bb0345","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s13277-014-2778-z","article-title":"Curcumin ameliorate DENA-induced HCC via modulating TGF-\u03b2, AKT, and caspase-3 expression in experimental rat model","volume":"36","author":"Abouzied","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2024.122669_bb0350","author":"Kamal Abouzed","year":"2021","journal-title":"The chemoprevention of spirulina platensis and garlic against diethylnitrosamine induced liver cancer in rats via amelioration of inf lammatory cytokines expression and oxidative stress"},{"key":"10.1016\/j.lfs.2024.122669_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.791272","article-title":"Transforming growth factor-Beta (TGF-\u03b2) signaling in Cancer-a betrayal within","volume":"13","author":"Baba","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122669_bb0360","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5114\/ceh.2018.78122","article-title":"Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis","volume":"4","author":"Shakiba","year":"2018","journal-title":"Clin. Exp. Hepatol."},{"key":"10.1016\/j.lfs.2024.122669_bb0365","first-page":"871","article-title":"Cell cycle control as a basis for cancer drug development (review)","volume":"16","author":"McDonald","year":"2000","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2024.122669_bb0370","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/fcp.12679","article-title":"The HIV reverse transcriptase inhibitor Tenofovir suppressed DMH\/HFD-induced colorectal cancer in Wistar rats","volume":"35","author":"Sherif","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122669_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092718","article-title":"Protective role of Vanillic acid against Diethylnitrosamine- and 1,2-Dimethylhydrazine-induced Hepatocarcinogenesis in rats","volume":"26","author":"Punvittayagul","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2024.122669_bb0380","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hep.27236","article-title":"Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma","volume":"60","author":"Peng","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2024.122669_bb0385","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.humpath.2007.03.002","article-title":"Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver","volume":"38","author":"Nakamura","year":"2007","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lfs.2024.122669_bb0390","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4161\/cbt.5.7.2754","article-title":"CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients","volume":"5","author":"Zhang","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2024.122669_bb0395","first-page":"881","article-title":"Molecular principles of cancer invasion and metastasis (review)","volume":"34","author":"Leber","year":"2009","journal-title":"Int. J. Oncol."}],"updated-by":[{"DOI":"10.1016\/j.lfs.2024.122669","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000}}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524002595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524002595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:50:51Z","timestamp":1715759451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524002595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":79,"alternative-id":["S0024320524002595"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122669","relation":{"retraction":[{"id-type":"doi","id":"10.1016\/j.lfs.2024.122669","asserted-by":"object"}]},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WITHDRAWN: Assessment of the therapeutic potential of a novel phosphoramidate acyclic nucleoside on induced hepatocellular carcinoma in rat model","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122669"}}